Machine Learning–Based Diagnostic Classification of Active Breast Cancer Using Clinical and Blood-Based Biochemical Biomarkers
Clinical and Experimental Obstetrics & Gynecology · 16.10.2026 · 53 (10)
DOI: 10.31083/ceog48645 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Obstetrics & Gynecology, online erschienen am 16.10.2026. Verfasst von Yiqi Lin und 7 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jilin Provincial Health Science and Technology Capacity Improvement Project.
Abstract (Originalsprache)
Background
Breast cancer remains the most frequently diagnosed malignancy among women globally, with rising incidence in low- and middle-income countries. Conventional screening methods, such as mammography, ultrasound, and magnetic resonance imaging (MRI), have limitations related to cost, accessibility, and diagnostic accuracy, highlighting the need for complementary strategies. This study aimed to improve the diagnostic classification of prevalent, undiagnosed breast cancer by integrating routine clinical variables with blood-based biochemical markers using machine learning models.
Methods
A retrospective cohort of 2000 women was analyzed from January to December 2024. Clinical parameters (age, menopausal status, family history, comorbidities) and routinely measured biomarkers (hemoglobin, red cell distribution width, platelet distribution width, mean corpuscular hemoglobin concentration, C-reactive protein, lipid profile, and fasting glucose) were included. Logistic regression, decision trees, random forests, extreme gradient boosting (XGBoost), and neural networks were trained and evaluated using stratified cross-validation. Model performance was evaluated using accuracy, sensitivity, specificity, F1-score, the receiver operating characteristic (ROC) curve, and the area under the curve (AUC). Feature importance was examined using Shapley additive explanations (SHAP) values to enhance interpretability.
Results
XGBoost achieved the highest diagnostic performance (accuracy 81.7%, AUC 0.86), followed closely by neural networks (accuracy 80.5%, AUC 0.85). The random forest also performed strongly (accuracy 78.0%, AUC 0.82). Logistic regression and decision tree models yielded lower accuracies of 71.0% and 69.2%, respectively. SHAP analysis identified platelet distribution width, age, red cell distribution width, hemoglobin, and C-reactive protein as the most influential predictors. The integrated model achieved an AUC of 0.86, compared with 0.77 for the clinical-only model and 0.78 for the biomarker-only model.
Conclusion
Machine learning models integrating clinical and biochemical data provide accurate, noninvasive, and scalable diagnostic classification of active breast cancer. By complementing imaging-based screening, such tools may support early identification of active breast cancer, particularly in resource-limited settings. Further validation in diverse populations and prospective clinical studies is warranted.
Förderung
- Jilin Provincial Health Science and Technology Capacity Improvement Project
Zitieren
APA
Lin, Y., Xu, D., Xu, F., Qi, D., Wang, Y., Cheng, K., Li, Y., & Zhang, J. (2026). Machine Learning–Based Diagnostic Classification of Active Breast Cancer Using Clinical and Blood-Based Biochemical Biomarkers. Clinical and Experimental Obstetrics & Gynecology, 53(10). https://doi.org/10.31083/ceog48645
Vancouver
Lin Y, Xu D, Xu F, Qi D, Wang Y, Cheng K, et al. Machine Learning–Based Diagnostic Classification of Active Breast Cancer Using Clinical and Blood-Based Biochemical Biomarkers. Clinical and Experimental Obstetrics & Gynecology. 2026;53(10). doi:10.31083/ceog48645
BibTeX
@article{Lin2026,
author = {Lin, Yiqi and Xu, Duo and Xu, Feng and Qi, Dianchun and Wang, Yiping and Cheng, Kunpeng and Li, Yuanyuan and Zhang, Jiaxin},
title = {Machine Learning–Based Diagnostic Classification of Active Breast Cancer Using Clinical and Blood-Based Biochemical Biomarkers},
journal = {Clinical and Experimental Obstetrics & Gynecology},
year = {2026},
volume = {53},
number = {10},
doi = {10.31083/ceog48645}
}
EUVIMED